Commission Regulation (EU) No 944/2013Dangos y teitl llawn

Commission Regulation (EU) No 944/2013 of 2 October 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)

ANNEX IU.K.

In Part 1, Table 6.2 of Annex IV to Regulation (EC) No 1272/2008, Code P210 is replaced by the following:

‘P210Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5
Flammable gases (section 2.2)1, 2
Aerosols (section 2.3)1, 2, 3
Flammable liquids (section 2.6)1, 2, 3
Flammable solids (section 2.7)1, 2
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
Oxidising liquids (section 2.13)1, 2, 3
Oxidising solids (section 2.14)1, 2, 3
Organic peroxides (section 2.15)Types A, B, C, D, E, F’

ANNEX IIU.K.

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingSpecific Conc. Limits,M — FactorsNotes
Hazard Class and Category Code(s)Hazard statement Code(s)Pictogram, Signal Word Code(s)Hazard statement Code(s)Suppl. Hazard statement Code(s)
015-004-00-8aluminium phosphide244-088-020859-73-8Water-react. 1H260GHS02H260EUH029M = 100
Acute Tox. 2H300GHS06H300EUH032
Acute Tox. 3H311GHS09H311
Acute Tox. 1H330DgrH330
Aquatic Acute 1H400H400
015-005-00-3

magnesium phosphide;

trimagnesium diphosphide

235-023-712057-74-8Water-react. 1H260GHS02H260EUH029M = 100
Acute Tox. 2H300GHS06H300EUH032
Acute Tox. 3H311GHS09H311
Acute Tox. 1H330DgrH330
Aquatic Acute 1H400H400
015-123-00-5

fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate

244-848-122224-92-6Acute Tox. 2H300GHS06H300

M = 100

M = 100

Acute Tox. 2H310GHS09H310
Acute Tox. 2H330DgrH330
Eye Irrit. 2H319H319
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9Aquatic Chronic 4H413H413
602-006-00-4

chloroform;

trichloromethane

200-663-867-66-3Carc. 2H351GHS06H351
Repr. 2H361dGHS08H361d
Acute Tox. 3H331DgrH331
Acute Tox. 4H302H302
STOT RE 1H372H372
Eye Irrit. 2H319H319
Skin Irrit. 2H315H315
603-097-00-3

1,1’,1’-nitrilotripropan-2-ol;

triisopropanolamine

204-528-4122-20-3Eye Irrit. 2H319

GHS07

Wng

H319
605-008-00-3

acrolein;

prop-2-enal;

acrylaldehyde

203-453-4107-02-8Flam. Liq. 2H225GHS02H225EUH071Skin Corr. 1; H314: C ≥ 0,1 %D
Acute Tox. 1H330GHS06H330
Acute Tox. 2H300GHS05H300
Acute Tox. 3H311GHS09H311
Skin Corr. 1H314DgrH314
Aquatic Acute 1H400M = 100
Aquatic Chronic 1H410H410M = 1
607-023-00-0vinyl acetate203-545-4108-05-4Flam. Liq. 2H225GHS02H225D
Carc. 2H351GHS08H351
Acute Tox. 4H332GHS07H332
STOT SE 3H335DgrH335
607-613-00-8

reaction mass of:

  • succinic acid

  • monopersuccinic acid

  • dipersuccinic acid

  • monomethyl ester of succinic acid

  • monomethyl ester of persuccinic acid

  • dimethyl succinate glutaric acid

  • monoperglutaric acid

  • diperglutaric acid

  • monomethyl ester of glutaric acid

  • monomethyl ester of perglutaric acid

  • dimethyl glutarate adipic acid

  • monoperadipic acid

  • diperadipic acid

  • monomethyl ester of adipic acid

  • monomethyl ester of peradipic acid

  • dimethyl adipate

  • hydrogen peroxide

  • methanol

  • water

432-790-1Acute Tox. 4*H332GHS07H332
Acute Tox. 4*H312GHS05H312
Acute Tox. 4*H302GHS08H302
Skin Corr. 1BH314DgrH314
STOT SE 2H371 (eyes)H371 (eyes)
609-003-00-7nitrobenzene202-716-098-95-3Carc. 2.H351GHS06H351
Repr. 1BH360FGHS08H360F
Acute Tox. 3H301DgrH301
Acute Tox. 3H331H331
Acute Tox. 3H311H311
STOT RE 1H372 (blood)H372 (blood)
Aquatic Chronic 3H412H412
612-120-00-6

aclonifen (ISO);

2-chloro-6-nitro-3-phenoxyaniline

277-704-174070-46-5Carc. 2H351GHS08H351

M = 100

M = 10

Skin Sens. 1AH317GHS07H317
Aquatic Acute 1H400GHS09
Aquatic Chronic 1H410WngH410
613-175-00-9

epoxiconazole (ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane

406-850-2133855-98-8Carc. 2H351GHS08H351
Repr. 1BH360DfGHS09H360Df
Aquatic Chronic 2H411DgrH411
616-200-00-1reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)432-430-3Aquatic Chronic 4H413H413
648-055-00-5

pitch, coal tar, high-temp.;

[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]

266-028-265996-93-2Carc. 1AH350GHS08H350

M = 1000

M = 1000

Muta. 1BH340GHS09H340
Repr. 1BH360FDDgrH360FD
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
649-330-00-2

naphtha (petroleum), hydrodesulphurized heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-185-464742-82-1Carc. 1BH350GHS08H350P
Muta. 1BH340DgrH340
STOT RE 1H372 (central nervous system)H372 (central nervous system)
Asp. Tox. 1H304H304
649-345-00-4

stoddard solvent;

Low boiling point naphtha — unspecified;

[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]

232-489-38052-41-3Carc. 1BH350GHS08H350P
Muta. 1BH340DgrH340
STOT RE 1H372 (central nervous system)H372 (central nervous system)
Asp. Tox. 1H304H304
649-405-00-X

solvent naphtha (petroleum), medium aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]

265-191-764742-88-7STOT RE 1H372 (central nervous system)GHS08H372 (central nervous system)
Asp. Tox. 1H304DgrH304

ANNEX IIIU.K.

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingSpecific Conc. Limits,M — FactorsNotes
Hazard Class and Category Code(s)Hazard statement Code(s)Pictogram, Signal Word Code(s)Hazard statement Code(s)Suppl. Hazard statement Code(s)
031-001-00-4gallium arsenide215-114-81303-00-0Carc. 1BH350GHS08H350
STOT RE 1H372 (respiratory and haematopoietic systems)DgrH372 (respiratory and haematopoietic systems)
050-025-00-6trichloromethylstannane213-608-8993-16-8Repr. 2H361d

GHS08

Wng

H361d
050-026-00-12-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate260-828-557583-34-3Repr. 2H361d

GHS08

Wng

H361d
050-027-00-72-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate239-622-415571-58-1Repr. 1BH360D

GHS08

Dgr

H360D
601-087-00-32,4,4-trimethylpentene246-690-925167-70-8Flam. Liq. 2H225GHS02H225D
Asp. Tox. 1H304GHS07H304
STOT SE 3H336

GHS08

Dgr

H336
606-145-00-1

sulcotrione (ISO);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8Repr. 2H361dGHS08H361d

M = 1

M = 10

STOT RE 2H373 (kidneys)GHS07H373 (kidneys)
Skin Sens. 1AH317GHS09H317
Aquatic Acute 1H400Wng
Aquatic Chronic 1H410H410
607-699-00-7

bifenthrin (ISO);

(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3Carc. 2H351GHS06H351

M = 10 000

M = 100 000

Acute Tox. 3H331GHS08H331
Acute Tox. 2H300GHS09H300
STOT RE 1H372 (nervous system)DgrH372 (nervous system)
Skin Sens. 1BH317H317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
607-700-00-0

indoxacarb (ISO);

methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]

173584-44-6 [1]Acute Tox. 3H301GHS06H301

M = 1

M = 1

Acute Tox. 4H332GHS08H332
STOT RE 1H372 (blood, nervous system, heart)GHS09H372 (blood, nervous system, heart)
Skin Sens. 1BH317DgrH317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;

methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]

144171-61-9 [2]
607-702-00-1dihexyl phthalate201-559-584-75-3Repr. 1BH360FD

GHS08

Dgr

H360FD
607-703-00-7ammoniumpentadeca- fluorooctanoate223-320-43825-26-1Carc. 2H351GHS08H351
Repr. 1BH360DGHS07H360D
Lact.H362GHS05H362
Acute Tox. 4H332DgrH332
Acute Tox. 4H302H302
STOT RE 1H372 (liver)H372 (liver)
Eye Dam.1H318H318
607-704-00-2perfluorooctanoic acid206-397-9335-67-1Carc. 2H351GHS08H351
Repr. 1BH360DGHS07H360D
Lact.H362GHS05H362
Acute Tox. 4H332DgrH332
Acute Tox. 4H302H302
STOT RE 1H372 (liver)H372 (liver)
Eye Dam. 1H318H318
612-282-00-8octadecylamine204-695-3124-30-1Asp. Tox. 1H304GHS05H304

M = 10

M = 10

STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS08H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2H315GHS09H315
Eye Dam. 1H318DgrH318
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-283-00-3(Z)-octadec-9-enylamine204-015-5112-90-3Acute Tox. 4H302GHS05H302

M = 10

M = 10

Asp Tox. 1H304GHS07H304
STOT SE 3H335GHS08H335
STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS09H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1BH314DgrH314
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-284-00-9amines, hydrogenated tallow alkyl262-976-661788-45-2Asp Tox. 1H304GHS08H304

M = 10

M = 10

STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS05H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2H315GHS09H315
Eye Dam. 1H318DgrH318
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-285-00-4amines, coco alkyl262-977-161788-46-3Acute Tox. 4H302GHS05H302

M = 10

M = 10

Asp. Tox. 1H304GHS07H304
STOT SE 3H335GHS08H335
STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS09H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1BH314DgrH314
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-286-00-Xamines, tallow alkyl263-125-161790-33-8Acute Tox. 4H302GHS05H302

M = 10

M = 10

Asp. Tox. 1H304GHS07H304
STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS08H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1BH314GHS09H314
Aquatic Acute 1H400Dgr
Aquatic Chronic 1H410H410
616-206-00-4

flufenoxuron (ISO);

1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3101463-69-8Lact.H362GHS09H362

M = 10 000

M = 10 000

Aquatic Acute 1H400Wng
Aquatic Chronic 1H410H410
616-207-00-Xpolyhexamethylene biguanide hydrochloride27083-27-8 or 32289-58-0Carc. 2H351GHS05H351

M = 10

M = 10

Acute Tox. 4H302GHS07H302
STOT RE 1H372 (respiratory tract) (inhalation)GHS08H372 (respiratory tract) (inhalation)
Eye Dam. 1H318GHS09H318
Skin Sens. 1BH317DgrH317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
616-208-00-5

N-ethyl-2-pyrrolidone;

1-ethylpyrrolidin-2-one

220-250-62687-91-4Repr. 1BH360D

GHS08

Dgr

H360D
616-209-00-0

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0120923-37-7Aquatic Acute 1H400GHS09

M = 100

M = 100

Aquatic Chronic 1H410WngH410
616-210-00-6

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide

119168-77-3Acute Tox. 3H301GHS06H301

M = 10

M = 10

Acute Tox. 4H332GHS08H332
STOT RE 2H373 (gastro-intestinal tract) (Oral)GHS09H373 (gastro-intestinal tract) (Oral)
Skin Sens. 1BH317DgrH317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
616-211-00-1

proquinazid (ISO);

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4Carc. 2H351GHS08H351

M = 1

M = 10

Aquatic Acute 1H400GHS09
Aquatic Chronic 1H410WngH410

ANNEX IVU.K.

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingConcentration LimitsNotes
015-004-00-8aluminium phosphide244-088-020859-73-8

F; R15/29

T+; R26/28

Xn; R21

R32

N; R50

F; T+; N

R: 15/29-21-26/28-32-50

S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

N; R50: C ≥ 0,25 %
015-005-00-3

magnesium phosphide;

trimagnesium diphosphide

235-023-712057-74-8

F; R15/29

T+; R26/28

Xn; R21

R32

N; R50

F; T+; N

R: 15/29-21-26/28-32-50

S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61

N; R50: C ≥ 0,25 %
015-123-00-5

fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate

244-848-122224-92-6

T+; R26/28

T; R24

Xi; R36

N; R50-53

T+; N

R: 24-26/28-36-50/53

S: (1/2-)23-26-28-35-36/37-45-60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9R53

R: 53

S: 61

602-006-00-4

chloroform;

trichloromethane

200-663-867-66-3

Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R20/22-48/20

Xi; R36/38

Xn

R: 20/22-36/38-40-48/20-63

S: (2-)36/37

603-097-00-3

1,1′,1′′-nitrilotripropan-2-ol;

triisopropanolamine

204-528-4122-20-3Xi; R36

Xi

R: 36

S: (2-)26

605-008-00-3

acrolein;

prop-2-enal;

acrylaldehyde

203-453-4107-02-8

F; R11

T+; R26/28

T; R24

C; R34

N; R50

F; T+; N

R: 11-24-26/28-34-50

S: (1/2-)23-26-28-36/37/39-45-61

C; R34: C ≥ 0,1 %

N; R50: C ≥ 0,25 %

D
607-023-00-0vinyl acetate203-545-4108-05-4

F; R11

Carc. Cat. 3; R40

Xn; R20

Xi; R37

F; Xn

R: 11-20-37-40

S: 9-16-33-36/37

D
607-613-00-8

reaction mass of:

  • succinic acid

  • monopersuccinic acid

  • dipersuccinic acid

  • monomethyl ester of succinic acid

  • monomethyl ester of persuccinic acid

  • dimethyl succinate

  • glutaric acid

  • monoperglutaric acid

  • diperglutaric acid

  • monomethyl ester of glutaric acid

  • monomethyl ester of perglutaric acid

  • dimethyl glutarate

  • adipic acid

  • monoperadipic acid

  • diperadipic acid

  • monomethyl ester of adipic acid

  • monomethyl ester of peradipic acid

  • dimethyl adipate

  • hydrogen peroxide

  • methanol

  • water

432-790-1

C; R34

Xn; R20/21/22-68/20/21/22

C

R: 20/21/22-34-68/20/21/22

S: (1/2-)26-28-36/37/39-45

609-003-00-7nitrobenzene202-716-098-95-3

Carc. Cat. 3; R40

Repr. Cat. 2; R60

T; R23/24/25-48/23/24/25

R52-53

T

R: 23/24/25-48/23/24/25-40-60-52/53

S: 45-53

612-120-00-6

aclonifen (ISO);

2-chloro-6-nitro-3-phenoxyaniline

277-704-174070-46-5

Carc. Cat. 3; R40

R43

N; R50-53

Xn; N

R: 40-43-50/53

S: (2-)36/37-60-61

R43: C ≥ 0,1 %

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

613-175-00-9

epoxiconazole (ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

406-850-2133855-98-8

Carc. Cat. 3; R40

Repr. Cat. 2; R61

Repr. Cat. 3; R62

N; R51-53

T; N

R: 61-40-62-51/53

S: 45-53-61

616-200-00-1reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)432-430-3R53

R: 53

S: 61

648-055-00-5

pitch, coal tar, high-temp.;

[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]

266-028-265996-93-2

Carc. Cat. 1; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

N; R50-53

T; N

R: 45-46-60-61-50/53

S: 45-53-60-61

N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C <

0,025 %

R52-53: 0,00025 % ≤ C <

0,0025 %

649-330-00-2

naphtha (petroleum), hydrodesulphurized heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-185-464742-82-1

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/20-65

T

R: 45-46-48/20-65

S: 45-53

P
649-345-00-4

stoddard solvent;

Low boiling point naphtha — unspecified;

[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]

232-489-38052-41-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/20-65

T

R: 45-46-48/20-65

S: 45-53

P
649-405-00-X

solvent naphtha (petroleum), medium aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]

265-191-764742-88-7Xn; R48/20-65

Xn

R: 48/20-65

S: (2-)23-24-62

ANNEX VU.K.

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingConcentration LimitsNotes
031-001-00-4gallium arsenide215-114-81303-00-0

Carc. Cat. 2; R45

T; R48/23

T

R: 45-48/23

S: 45-53

E
050-025-00-6trichloromethylstannane213-608-8993-16-8Repr. Cat. 3; R63

Xn

R: 63

S: (2-)22-36/37

050-026-00-12-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate260-828-557583-34-3Repr. Cat. 3; R63

Xn

R: 63

S: (2-)22-36/37

050-027-00-72-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate239-622-415571-58-1Repr. Cat. 2; R61

T

R: 61

S: 45-53

601-087-00-32,4,4-trimethylpentene246-690-925167-70-8

F; R11

Xn; R65

R67

F; Xn

R: 11-65-67

S: 9-16-33-62

D
606-145-00-1

sulcotrione (ISO);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8

Repr. Cat. 3; R63

Xn; R48/22

R43

N; R50-53

Xn; N

R: 43-48/22-63-50/53

S: (2-)22-36/37-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C< 2,5 %

R43: C ≥ 0,1 %

607-699-00-7

bifenthrin (ISO);

(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3

Carc. Cat 3; R40

T; R23/25

Xn; R48/22

R43

N; R50-53

T; N

R: 23/25-40-43-48/22-50/53

S: (1/2-)23-24-36/37-38- 45-60-61

N; R50-53: C ≥ 0,0025 %

N; R51-53: 0,00025 % ≤ C< 0,0025 %

R52-53: 0,000025 % ≤ C < 0,00025 %

607-700-00-0

indoxacarb (ISO);

methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate

173584-44-6

T; R25-48/25

Xn; R20

R43

N; R50-53

T; N

R: 20-25-43-48/25-50/53

S: (1/2-)24-37-45-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

607-701-00-6

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;

methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate

144171-61-9

T; R48/25

Xn; R20/22

R43

N; R50-53

T; N

R: 20/22-43-48/25-50/53

S: (1/2-)24-37-45-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

607-702-00-1dihexyl phthalate201-559-584-75-3Repr. Cat. 2; R60-61

T

R: 60-61

S: 45-53

607-703-00-7ammoniumpentade-cafluorooctanoate223-320-43825-26-1

Carc. Cat. 3; R40

Repr. Cat. 2; R61

R64

T; R48/23

Xn; R20/22-48/21/22

Xi; R41

T

R: 61-20/22-40-41- 48/23-48/21/22-64

S: 45-53

607-704-00-2perfluorooctanoic acid206-397-9335-67-1

Carc. Cat. 3; R40

Repr. Cat. 2; R61

R64

T; R48/23

Xn; R20/22-48/21/22

Xi; R41

T

R: 61-20/22-40-41-48/23-48/21/22-64

S: 45-53

612-282-00-8octadecylamine204-695-3124-30-1

Xn; R48/22-65

Xi; R38-41

N; R50-53

Xn; N

R: 38-41-48/22-65-50/53

S: (2-)26-36/37/39-60-61-62

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-283-00-3(Z)-octadec-9-enylamine204-015-5112-90-3

Xn; R22-48/22-65

C; R34

N; R50-53

C; N

R: 22-34-48/22-65-50/53

S: (1/2-)23-26-36/37/39-45-60-61-62

C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-284-00-9amines, hydrogenated tallow alkyl262-976-661788-45-2

Xn; R48/22-65

Xi; R38-41

N; R50-53

Xn; N

R: 38-41-48/22-65-50/53

S: (2-)26-36/37/39-60-61-62

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-285-00-4amines, coco alkyl262-977-161788-46-3

Xn; R22-48/22-65

C; R35

N; R50-53

C; N

R: 22-35-48/22-65-50/53

S: (1/2-)23-26-36/37/39-45-60-61-62

C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

612-286-00-Xamines, tallow alkyl263-125-161790-33-8

Xn; R22-48/22-65

C; R35

N; 50-53

C; N

R: 22-35-48/22-65-50/53

S: (1/2-)26-36/37/39-45-60-61-62

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-206-00-4

flufenoxuron (ISO);

1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3101463-69-8

R64

R33

N; R50-53

N

R: 33-64-50/53

S: (2-)22-36/37-46-60-61

N; R50-53 C ≥ 0,0025 %

N; R51-53 0,00025 % ≤ C < 0,0025 %

R52-53 0,000025 % ≤ C < 0,00025 %

616-207-00-Xpolyhexamethylene biguanide hydrochloride27083-27-8 or 32289-58-0

Carc. Cat 3; R40

Xn; R22

T; R48/23

Xi; R41

R43

N; R50-53

T; N

R: 22-40-41-43-48/23-50/53

S: (1/2-)22-36/37/39-45-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-208-00-5

N-ethyl-2-pyrrolidone;

1-ethylpyrrolidin-2-one

220-250-62687-91-4Repr. Cat. 2; R61

T

R: 61

S: 45-53

616-209-00-0

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0120923-37-7N; R50-53

N

R: 50/53

S: 60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

616-210-00-6

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5-carboxamide

119168-77-3

Xn; R20/22

R43

N; R50-53

Xn; N

R: 20/22-43-50/53

S: (2-)24-37-46-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-211-00-1

proquinazid (ISO);

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61